Cases & Deals

Jazz Pharmaceuticals files patent infringement claims against Roxane Laboratories over generic version of XYREM®

Clients Jazz Pharmaceuticals, Inc.

Jones Day represents plaintiff Jazz Pharmaceuticals, Inc. in a Hatch-Waxman ANDA patent litigation involving a proposed generic version of sodium oxybate, which is sold under the brand name XYREM®, and is prescribed in the treatment of narcolepsy.

Jazz Pharmaceuticals, Inc. v. Roxane Laboratories, Inc., Civil Action No. 2-10-cv-06108 (D.N.J.) (Judge Wigenton)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.